- 全部删除
- 您的购物车当前为空
JB170是一种高效和特异性的Aurora A降解剂 (DC50=28 nM),PROTAC由Alisertib和Thalidomide组成,对AURORA-A的EC50值是AURORA-B的十倍,能够引起细胞生长的S期阻滞并抑制AURORA-A激酶的非催化功能。
为众多的药物研发团队赋能,
让新药发现更简单!
JB170是一种高效和特异性的Aurora A降解剂 (DC50=28 nM),PROTAC由Alisertib和Thalidomide组成,对AURORA-A的EC50值是AURORA-B的十倍,能够引起细胞生长的S期阻滞并抑制AURORA-A激酶的非催化功能。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 948 | In stock | |
5 mg | ¥ 2,350 | In stock | |
10 mg | ¥ 3,500 | In stock | |
25 mg | ¥ 5,660 | In stock | |
50 mg | ¥ 7,830 | In stock |
JB170 相关产品
产品描述 | JB170 is a highly efficient and specific Aurora A degradator (DC50 = 28 nM). The PROTAC is composed of Alisertib and Thalidomide, with an EC50 value for AURORA-A that is ten times that of AURORA-B. It induces S-phase arrest in cell growth and inhibits the non-catalytic function of the AURORA-A kinase. |
靶点活性 | Aurora A:28 nM (DC50), Aurora A:99 nM (Kd), Aurora A:193 nM (EC50) |
别名 | JB 170 |
分子量 | 963.36 |
分子式 | C48H44ClFN8O11 |
CAS No. | 2705844-82-0 |
Smiles | O=C(NCCOCCOCCNC(=O)COC1=CC=CC=2C(=O)N(C(=O)C12)C3C(=O)NC(=O)CC3)C4=CC=C(C=C4OC)NC=5N=CC6=C(N5)C=7C=CC(Cl)=CC7C(=NC6)C=8C(F)=CC=CC8OC |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (83.04 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容